Hyper-targeted small molecules for reprogramming immune cells to treat disease
MorphImmune, Inc. addresses significant unmet medical needs by selectively targeting
and reprogramming dysregulated immune cells that cause or promote disease
MorphImmune, Inc. addresses significant unmet medical needs by selectively targeting
and reprogramming dysregulated immune cells that cause or promote disease